MedPath

Assessment of combined exercise training effect in men with primary hypertensio

Not Applicable
Conditions
Primary hypertension.
Essential (primary) hypertension
Registration Number
IRCT20160317027092N2
Lead Sponsor
Birjand University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
60
Inclusion Criteria

Age range between 30-70 years is allowed.
According to a specialist doctor's diagnosis, they have primary hypertension and at least one year has passed since their illness
Doctors' permission to participate in an exercise program and no need for a specific drug (calcium channel blockers such as verapamil that significantly decrease TXNIP in Langerhans beta cells) (Poudel & Kafle, 2017), at least until Completion of the research period (10 weeks) is required
Do not take more than one type of antihypertensive pill daily
Their minimum systolic blood pressure was 140 mmHg and diastolic blood pressure was 90 mmHg.
They do not have a history of regular exercise in the six months leading up to the time of the study
People should not participate in specific weight loss programs
Do not have diabetes, fatty liver, Hypothyroidism or hyperthyroidism, anemia (Hb <10 g / dl) and kidney disease (> 1.5 mg / dl creatinine) and Do not have a history of Myocardial infarction, heart attack, cardiac arrhythmia Also do not have ischemic heart disease or unstable angina (Farinatti et al., 2016). This informationwill be obtained through the medical records of individuals.
They have no history of any heart surgery

Exclusion Criteria

Having bone, muscles, and joints problems that prevent exercise.
Have a blood pressure higher than 180 mmHg.
Take calcium channel blocker drugs such as verapamil, amlodipine, diltiazem.
Smoking or addiction to any drug or alcohol (Moraes et al., 2012).
Participate in any other exercise program (recreational or professional) while conducting research.
Have no interest in participating in a sports activity program.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath